IBM Retirement Fund’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-69,395
Closed -$26K 909
2016
Q4
$26K Hold
69,395
﹤0.01% 909
2016
Q3
$19K Hold
69,395
﹤0.01% 947
2016
Q2
$17K Hold
69,395
﹤0.01% 974
2016
Q1
$8K Hold
69,395
﹤0.01% 967
2015
Q4
$8K Buy
+69,395
New +$9.8K ﹤0.01% 1119
2015
Q3
Sell
-69,395
Closed -$49K 1044
2015
Q2
$49K Hold
69,395
﹤0.01% 1033
2015
Q1
$47K Hold
69,395
﹤0.01% 1040
2014
Q4
$55K Hold
69,395
﹤0.01% 1041
2014
Q3
$32K Hold
69,395
﹤0.01% 1029
2014
Q2
$35K Hold
69,395
﹤0.01% 1028
2014
Q1
$22K Hold
69,395
﹤0.01% 1016
2013
Q4
$24K Hold
69,395
﹤0.01% 1021
2013
Q3
$140K Hold
69,395
﹤0.01% 1015
2013
Q2
$134K Buy
+69,395
New +$122K ﹤0.01% 1023

Other funds holding GCVRZ

IBM Retirement Fund's GCVRZ Position: Q1 2017 in Review

IBM Retirement Fund sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2017, closing a stake of 69,395 shares — an estimated $26K sold.

IBM Retirement Fund first reported a position in GCVRZ in Q2 2013 and held it in 14 quarters. The position peaked at $140K in Q3 2013. 111 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2017.

  • IBM Retirement Fund reported no remaining Sanofi Contingent Value Rights position as of Q1 2017 after selling out during the quarter.
  • IBM Retirement Fund sold 69,395 Sanofi Contingent Value Rights shares in Q1 2017, an estimated $26K.
  • IBM Retirement Fund first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 14 quarters.
  • IBM Retirement Fund's Sanofi Contingent Value Rights position peaked at $140K in Q3 2013.
  • 111 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2017.

Based on IBM Retirement Fund's 13F filing for Q1 2017, filed 10 May 2017.